Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2000
03/16/2000WO2000013694A1 Gcp
03/16/2000WO2000006694A3 Compound and method for the prevention and/or the treatment of allergy
03/16/2000WO2000003029A3 Chimaeric adenoviruses
03/16/2000WO2000002910A3 Human fast-1 gene
03/16/2000WO2000002897A3 Delta cleavage products and methods based thereon
03/16/2000WO2000000512A3 Antifreeze polypeptides from myoxocephalus scorpius and their nucleic acids
03/16/2000WO1999067391A9 Origin of replication and methods of use
03/16/2000WO1999067286A3 Novel staphylococcus peptides for bacterial interference
03/16/2000WO1999065937A9 Truncated apaf-1 and methods of use thereof
03/16/2000WO1999064598A3 Novel insulin analogs with enhanced zinc binding
03/16/2000WO1999064592A9 Green fluorescent proteins for measuring the ph of a biological sample
03/16/2000WO1999063941A3 Novel hepatitis c virus peptides and uses thereof
03/16/2000WO1999062939A3 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/16/2000WO1999062927A9 Connective tissue growth factor-4
03/16/2000WO1999061471A3 Human transmembrane proteins
03/16/2000WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
03/16/2000WO1999058559B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
03/16/2000WO1999053064A3 Methods of delivering glp-1
03/16/2000WO1999050404A3 Transgenic animals with inducible protein expression and methods of use
03/16/2000WO1999046385A3 Compositions and methods for the treatment and prevention of metastatic disorders
03/16/2000WO1999012561A9 FRACTURE HEALING USING PTHrP ANALOGS
03/16/2000WO1998049327A8 Recombinant fusion proteines based on bacterial adhesines for diagnostic assays
03/16/2000DE19841941A1 A novel metabotropic receptor complex from the central nervous system, related coding sequences and methods of identifying binding substances, ligands and interactions with other proteins
03/16/2000DE19830907A1 Verfahren zur Optimierung der Produktion von Adenovirus-Vektoren A method for optimizing the production of adenovirus vectors
03/16/2000CA2346430A1 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins
03/16/2000CA2345050A1 Method of using fetuin to induce apoptosis in cancer cells
03/16/2000CA2343156A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof
03/16/2000CA2342984A1 Recombinant human sm-11044-binding receptor protein having activity of binding to ligand and utilization thereof
03/16/2000CA2342859A1 Production of human erythropoietin
03/16/2000CA2342849A1 Methods for generating high titer helper-free preparations of released recombinant aav vectors
03/16/2000CA2342792A1 Enzymatic oxidative deamination process
03/16/2000CA2342070A1 Grf analogs with increased biological potency
03/16/2000CA2342027A1 Novel bag proteins and nucleic acid molecules encoding them
03/16/2000CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus
03/16/2000CA2341777A1 Neutral amino acid transporter and gene thereof
03/16/2000CA2341760A1 17 kda foam protein
03/16/2000CA2341498A1 Temperature dependent protein purification
03/16/2000CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof
03/16/2000CA2341326A1 Novel protein and process for producing the same
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2341314A1 Method for studying protein interactions in vivo
03/16/2000CA2341302A1 Lim domain protein homolog
03/16/2000CA2341259A1 Crystalline forms of eto2c-ch2-(r)cgl-aze-pab-oh
03/16/2000CA2341154A1 Novel receptor protein and method for the diagnosis of an inflammatory disease by using the same
03/16/2000CA2341153A1 Monitor protein for measuring protein phosphorylation
03/16/2000CA2341149A1 Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1)
03/16/2000CA2340686A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
03/16/2000CA2340598A1 Modifications of the vegf receptor-2 protein and methods of use
03/16/2000CA2340323A1 Mc4-r as target for the identification of compounds used to treat drug addiction
03/16/2000CA2338384A1 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants
03/16/2000CA2309212A1 Essential bacterial genes and their use
03/15/2000EP0985931A2 Recombinant antigen immunoassay for the diagnosis of syphilis
03/15/2000EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein
03/15/2000EP0985729A2 Streptokinase mutants
03/15/2000EP0985149A1 Methods for evaluating tissue morphogenesis and activity
03/15/2000EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES
03/15/2000EP0985051A1 Nucleic acid probes for the detection and identification of fungi
03/15/2000EP0985047A2 Somatic gene therapy to suppress secondary cataract formation
03/15/2000EP0985046A1 A soluble vaccinia virus protein that binds chemokines
03/15/2000EP0985045A2 Modulators of morphogen expression and methods of identifying the same
03/15/2000EP0985044A1 Anti-cancer vaccine
03/15/2000EP0985041A1 Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process
03/15/2000EP0985040A1 Preparation of glycosylated tumor necrosis factor
03/15/2000EP0985039A2 Artificial antibody polypeptides
03/15/2000EP0985038A1 Sodium channel receptor
03/15/2000EP0985037A1 Human multiple endocrine neoplasia type 1 protein
03/15/2000EP0985036A1 Zinc ring protein
03/15/2000EP0985034A1 Methods of controlling beta dimer formation in hemoglobin
03/15/2000EP0985033A2 Polyvalent and polyclonal libraries
03/15/2000EP0984987A2 A soluble laminin receptor precursor and methods to ihnibit its interactions
03/15/2000EP0984986A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
03/15/2000EP0984985A2 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis
03/15/2000EP0984984A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
03/15/2000EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain
03/15/2000EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use
03/15/2000EP0984784A2 Anti-cancer products for treating cystic fibrosis
03/15/2000EP0984699A1 Method of inhibiting immune system destruction of transplanted viable cells
03/15/2000EP0842434B1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody
03/15/2000EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS
03/15/2000EP0741791B1 Cd 69 transcriptional regulatory elements
03/15/2000EP0736040B1 Use of igf-bp for refolding of igf
03/15/2000EP0734441B1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi
03/15/2000EP0723453B1 Method of treating reproductive disorders
03/15/2000EP0667781B1 Peptide diagnostics and therapeutics for spondyloarthropathies
03/15/2000EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy
03/15/2000EP0651812B1 Modular promoter construct
03/15/2000EP0649468B1 Soluble cr1 derivatives
03/15/2000EP0648279B1 Acceptor for fucosyltransferase
03/15/2000EP0643584B1 Delivery of a cytotoxic compound to a cancer cell using a pathway of plasminogen activator material
03/15/2000EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR
03/15/2000EP0610286B1 Recombinant immunotoxins
03/15/2000EP0567566B1 Methods for treating tumor necrosis factor mediated diseases
03/15/2000EP0563311B1 Improved vaccines
03/15/2000EP0551325B1 Method of testing for salmonella
03/15/2000EP0541726B1 Growth factor compositions, preparation and use
03/15/2000EP0506785B1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
03/15/2000EP0434721B1 Viral nucleotide sequences
03/15/2000CN1247568A Fibroblast growth factor homologs
03/15/2000CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6
03/15/2000CN1247566A Novel peptide, novel DNA, and novel antibody
1 ... 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 ... 2916